nodes	percent_of_prediction	percent_of_DWPC	metapath
Melphalan—Chlorambucil—testicular cancer	0.363	1	CrCtD
Melphalan—Alkylating Activity—Ifosfamide—testicular cancer	0.206	0.529	CiPCiCtD
Melphalan—ovarian cancer—testicular cancer	0.2	1	CtDrD
Melphalan—Alkylating Activity—Chlorambucil—testicular cancer	0.184	0.471	CiPCiCtD
Melphalan—SLC7A5—seminal vesicle—testicular cancer	0.000586	0.171	CbGeAlD
Melphalan—SLC7A5—gonad—testicular cancer	0.000423	0.123	CbGeAlD
Melphalan—SLC22A3—embryo—testicular cancer	0.000387	0.113	CbGeAlD
Melphalan—SLC22A3—seminal vesicle—testicular cancer	0.000364	0.106	CbGeAlD
Melphalan—SLC7A5—female gonad—testicular cancer	0.000344	0.1	CbGeAlD
Melphalan—SLC7A5—testis—testicular cancer	0.000305	0.0889	CbGeAlD
Melphalan—SLC22A3—gonad—testicular cancer	0.000263	0.0765	CbGeAlD
Melphalan—SLC7A5—lymph node—testicular cancer	0.000221	0.0644	CbGeAlD
Melphalan—SLC22A3—female gonad—testicular cancer	0.000214	0.0622	CbGeAlD
Melphalan—SLC22A3—testis—testicular cancer	0.000189	0.0552	CbGeAlD
Melphalan—SLC22A3—lymph node—testicular cancer	0.000137	0.04	CbGeAlD
Melphalan—Oedema—Ifosfamide—testicular cancer	3.8e-05	0.000874	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Dactinomycin—testicular cancer	3.78e-05	0.000869	CcSEcCtD
Melphalan—Asthenia—Vinblastine—testicular cancer	3.78e-05	0.000869	CcSEcCtD
Melphalan—Infection—Ifosfamide—testicular cancer	3.78e-05	0.000868	CcSEcCtD
Melphalan—Alopecia—Etoposide—testicular cancer	3.73e-05	0.000859	CcSEcCtD
Melphalan—Thrombocytopenia—Ifosfamide—testicular cancer	3.72e-05	0.000856	CcSEcCtD
Melphalan—Anaemia—Cisplatin—testicular cancer	3.71e-05	0.000853	CcSEcCtD
Melphalan—Renal failure acute—Epirubicin—testicular cancer	3.71e-05	0.000853	CcSEcCtD
Melphalan—Skin disorder—Ifosfamide—testicular cancer	3.69e-05	0.000849	CcSEcCtD
Melphalan—Vomiting—Chlorambucil—testicular cancer	3.65e-05	0.00084	CcSEcCtD
Melphalan—Anorexia—Ifosfamide—testicular cancer	3.62e-05	0.000833	CcSEcCtD
Melphalan—Decreased appetite—Dactinomycin—testicular cancer	3.61e-05	0.000829	CcSEcCtD
Melphalan—Diarrhoea—Vinblastine—testicular cancer	3.6e-05	0.000828	CcSEcCtD
Melphalan—Leukopenia—Cisplatin—testicular cancer	3.59e-05	0.000826	CcSEcCtD
Melphalan—Fatigue—Dactinomycin—testicular cancer	3.58e-05	0.000822	CcSEcCtD
Melphalan—Hypotension—Ifosfamide—testicular cancer	3.55e-05	0.000817	CcSEcCtD
Melphalan—Pain—Dactinomycin—testicular cancer	3.55e-05	0.000816	CcSEcCtD
Melphalan—Urticaria—Bleomycin—testicular cancer	3.53e-05	0.000812	CcSEcCtD
Melphalan—Convulsion—Cisplatin—testicular cancer	3.48e-05	0.0008	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Ifosfamide—testicular cancer	3.46e-05	0.000796	CcSEcCtD
Melphalan—Hyponatraemia—Epirubicin—testicular cancer	3.44e-05	0.00079	CcSEcCtD
Melphalan—Renal failure acute—Doxorubicin—testicular cancer	3.43e-05	0.000789	CcSEcCtD
Melphalan—Myalgia—Cisplatin—testicular cancer	3.42e-05	0.000786	CcSEcCtD
Melphalan—Nausea—Chlorambucil—testicular cancer	3.41e-05	0.000785	CcSEcCtD
Melphalan—Paraesthesia—Ifosfamide—testicular cancer	3.41e-05	0.000785	CcSEcCtD
Melphalan—Anaemia—Etoposide—testicular cancer	3.4e-05	0.000782	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	3.39e-05	0.000781	CcSEcCtD
Melphalan—Dyspnoea—Ifosfamide—testicular cancer	3.39e-05	0.000779	CcSEcCtD
Melphalan—Liver function test abnormal—Methotrexate—testicular cancer	3.38e-05	0.000777	CcSEcCtD
Melphalan—Vomiting—Vinblastine—testicular cancer	3.35e-05	0.00077	CcSEcCtD
Melphalan—Decreased appetite—Ifosfamide—testicular cancer	3.3e-05	0.00076	CcSEcCtD
Melphalan—Leukopenia—Etoposide—testicular cancer	3.29e-05	0.000757	CcSEcCtD
Melphalan—Gastrointestinal disorder—Ifosfamide—testicular cancer	3.28e-05	0.000755	CcSEcCtD
Melphalan—Fatigue—Ifosfamide—testicular cancer	3.28e-05	0.000753	CcSEcCtD
Melphalan—Anaphylactic shock—Cisplatin—testicular cancer	3.28e-05	0.000753	CcSEcCtD
Melphalan—Oedema—Cisplatin—testicular cancer	3.28e-05	0.000753	CcSEcCtD
Melphalan—Hypersensitivity—Bleomycin—testicular cancer	3.28e-05	0.000753	CcSEcCtD
Melphalan—Cardiac arrest—Epirubicin—testicular cancer	3.26e-05	0.000749	CcSEcCtD
Melphalan—Infection—Cisplatin—testicular cancer	3.26e-05	0.000749	CcSEcCtD
Melphalan—Pain—Ifosfamide—testicular cancer	3.25e-05	0.000747	CcSEcCtD
Melphalan—Cough—Etoposide—testicular cancer	3.21e-05	0.000738	CcSEcCtD
Melphalan—Thrombocytopenia—Cisplatin—testicular cancer	3.21e-05	0.000738	CcSEcCtD
Melphalan—Tachycardia—Cisplatin—testicular cancer	3.2e-05	0.000735	CcSEcCtD
Melphalan—Asthenia—Bleomycin—testicular cancer	3.19e-05	0.000734	CcSEcCtD
Melphalan—Convulsion—Etoposide—testicular cancer	3.19e-05	0.000733	CcSEcCtD
Melphalan—Skin disorder—Cisplatin—testicular cancer	3.18e-05	0.000732	CcSEcCtD
Melphalan—Hyponatraemia—Doxorubicin—testicular cancer	3.18e-05	0.000731	CcSEcCtD
Melphalan—Liver function test abnormal—Epirubicin—testicular cancer	3.16e-05	0.000727	CcSEcCtD
Melphalan—Pruritus—Bleomycin—testicular cancer	3.15e-05	0.000723	CcSEcCtD
Melphalan—Chest pain—Etoposide—testicular cancer	3.13e-05	0.00072	CcSEcCtD
Melphalan—Nausea—Vinblastine—testicular cancer	3.13e-05	0.000719	CcSEcCtD
Melphalan—Anorexia—Cisplatin—testicular cancer	3.12e-05	0.000718	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	3.11e-05	0.000715	CcSEcCtD
Melphalan—Hypotension—Cisplatin—testicular cancer	3.06e-05	0.000704	CcSEcCtD
Melphalan—Hypersensitivity—Dactinomycin—testicular cancer	3.06e-05	0.000703	CcSEcCtD
Melphalan—Urticaria—Ifosfamide—testicular cancer	3.02e-05	0.000694	CcSEcCtD
Melphalan—Cardiac arrest—Doxorubicin—testicular cancer	3.01e-05	0.000693	CcSEcCtD
Melphalan—Pancytopenia—Methotrexate—testicular cancer	3e-05	0.00069	CcSEcCtD
Melphalan—Anaphylactic shock—Etoposide—testicular cancer	3e-05	0.00069	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Cisplatin—testicular cancer	2.99e-05	0.000686	CcSEcCtD
Melphalan—Infection—Etoposide—testicular cancer	2.98e-05	0.000686	CcSEcCtD
Melphalan—Asthenia—Dactinomycin—testicular cancer	2.98e-05	0.000684	CcSEcCtD
Melphalan—Neutropenia—Methotrexate—testicular cancer	2.96e-05	0.00068	CcSEcCtD
Melphalan—Paraesthesia—Cisplatin—testicular cancer	2.94e-05	0.000677	CcSEcCtD
Melphalan—Thrombocytopenia—Etoposide—testicular cancer	2.94e-05	0.000676	CcSEcCtD
Melphalan—Tachycardia—Etoposide—testicular cancer	2.93e-05	0.000674	CcSEcCtD
Melphalan—Liver function test abnormal—Doxorubicin—testicular cancer	2.92e-05	0.000673	CcSEcCtD
Melphalan—Dyspnoea—Cisplatin—testicular cancer	2.92e-05	0.000672	CcSEcCtD
Melphalan—Skin disorder—Etoposide—testicular cancer	2.92e-05	0.00067	CcSEcCtD
Melphalan—Anorexia—Etoposide—testicular cancer	2.86e-05	0.000658	CcSEcCtD
Melphalan—Decreased appetite—Cisplatin—testicular cancer	2.85e-05	0.000655	CcSEcCtD
Melphalan—Diarrhoea—Dactinomycin—testicular cancer	2.84e-05	0.000653	CcSEcCtD
Melphalan—Gastrointestinal disorder—Cisplatin—testicular cancer	2.83e-05	0.00065	CcSEcCtD
Melphalan—Vomiting—Bleomycin—testicular cancer	2.83e-05	0.00065	CcSEcCtD
Melphalan—Pancytopenia—Epirubicin—testicular cancer	2.81e-05	0.000646	CcSEcCtD
Melphalan—Hypotension—Etoposide—testicular cancer	2.81e-05	0.000645	CcSEcCtD
Melphalan—Rash—Bleomycin—testicular cancer	2.8e-05	0.000645	CcSEcCtD
Melphalan—Pain—Cisplatin—testicular cancer	2.8e-05	0.000644	CcSEcCtD
Melphalan—Dermatitis—Bleomycin—testicular cancer	2.8e-05	0.000644	CcSEcCtD
Melphalan—Hypersensitivity—Ifosfamide—testicular cancer	2.8e-05	0.000644	CcSEcCtD
Melphalan—Neutropenia—Epirubicin—testicular cancer	2.77e-05	0.000636	CcSEcCtD
Melphalan—Stomatitis—Methotrexate—testicular cancer	2.75e-05	0.000632	CcSEcCtD
Melphalan—Asthenia—Ifosfamide—testicular cancer	2.73e-05	0.000627	CcSEcCtD
Melphalan—Paraesthesia—Etoposide—testicular cancer	2.7e-05	0.00062	CcSEcCtD
Melphalan—Pruritus—Ifosfamide—testicular cancer	2.69e-05	0.000618	CcSEcCtD
Melphalan—Dyspnoea—Etoposide—testicular cancer	2.68e-05	0.000615	CcSEcCtD
Melphalan—Hepatobiliary disease—Methotrexate—testicular cancer	2.67e-05	0.000613	CcSEcCtD
Melphalan—Nausea—Bleomycin—testicular cancer	2.64e-05	0.000607	CcSEcCtD
Melphalan—Vomiting—Dactinomycin—testicular cancer	2.64e-05	0.000606	CcSEcCtD
Melphalan—Rash—Dactinomycin—testicular cancer	2.62e-05	0.000601	CcSEcCtD
Melphalan—Decreased appetite—Etoposide—testicular cancer	2.61e-05	0.0006	CcSEcCtD
Melphalan—Diarrhoea—Ifosfamide—testicular cancer	2.6e-05	0.000598	CcSEcCtD
Melphalan—Pancytopenia—Doxorubicin—testicular cancer	2.6e-05	0.000598	CcSEcCtD
Melphalan—Gastrointestinal disorder—Etoposide—testicular cancer	2.59e-05	0.000596	CcSEcCtD
Melphalan—Fatigue—Etoposide—testicular cancer	2.59e-05	0.000595	CcSEcCtD
Melphalan—Neuropathy peripheral—Epirubicin—testicular cancer	2.59e-05	0.000595	CcSEcCtD
Melphalan—Stomatitis—Epirubicin—testicular cancer	2.57e-05	0.000591	CcSEcCtD
Melphalan—Jaundice—Epirubicin—testicular cancer	2.57e-05	0.000591	CcSEcCtD
Melphalan—Pain—Etoposide—testicular cancer	2.57e-05	0.00059	CcSEcCtD
Melphalan—Neutropenia—Doxorubicin—testicular cancer	2.56e-05	0.000589	CcSEcCtD
Melphalan—Haemoglobin—Methotrexate—testicular cancer	2.54e-05	0.000585	CcSEcCtD
Melphalan—Haemorrhage—Methotrexate—testicular cancer	2.53e-05	0.000582	CcSEcCtD
Melphalan—Hepatitis—Methotrexate—testicular cancer	2.53e-05	0.000582	CcSEcCtD
Melphalan—Urinary tract disorder—Methotrexate—testicular cancer	2.5e-05	0.000575	CcSEcCtD
Melphalan—Hepatobiliary disease—Epirubicin—testicular cancer	2.5e-05	0.000574	CcSEcCtD
Melphalan—Urethral disorder—Methotrexate—testicular cancer	2.48e-05	0.00057	CcSEcCtD
Melphalan—Nausea—Dactinomycin—testicular cancer	2.46e-05	0.000567	CcSEcCtD
Melphalan—Vomiting—Ifosfamide—testicular cancer	2.42e-05	0.000556	CcSEcCtD
Melphalan—Hypersensitivity—Cisplatin—testicular cancer	2.41e-05	0.000555	CcSEcCtD
Melphalan—Rash—Ifosfamide—testicular cancer	2.4e-05	0.000551	CcSEcCtD
Melphalan—Dermatitis—Ifosfamide—testicular cancer	2.39e-05	0.000551	CcSEcCtD
Melphalan—Neuropathy peripheral—Doxorubicin—testicular cancer	2.39e-05	0.00055	CcSEcCtD
Melphalan—Urticaria—Etoposide—testicular cancer	2.38e-05	0.000548	CcSEcCtD
Melphalan—Haemoglobin—Epirubicin—testicular cancer	2.38e-05	0.000547	CcSEcCtD
Melphalan—Stomatitis—Doxorubicin—testicular cancer	2.38e-05	0.000547	CcSEcCtD
Melphalan—Jaundice—Doxorubicin—testicular cancer	2.38e-05	0.000547	CcSEcCtD
Melphalan—Hepatitis—Epirubicin—testicular cancer	2.37e-05	0.000545	CcSEcCtD
Melphalan—Haemorrhage—Epirubicin—testicular cancer	2.37e-05	0.000545	CcSEcCtD
Melphalan—Asthenia—Cisplatin—testicular cancer	2.35e-05	0.000541	CcSEcCtD
Melphalan—Urinary tract disorder—Epirubicin—testicular cancer	2.34e-05	0.000538	CcSEcCtD
Melphalan—Connective tissue disorder—Epirubicin—testicular cancer	2.33e-05	0.000535	CcSEcCtD
Melphalan—Urethral disorder—Epirubicin—testicular cancer	2.32e-05	0.000534	CcSEcCtD
Melphalan—Hepatobiliary disease—Doxorubicin—testicular cancer	2.31e-05	0.000531	CcSEcCtD
Melphalan—Immune system disorder—Methotrexate—testicular cancer	2.29e-05	0.000526	CcSEcCtD
Melphalan—Mediastinal disorder—Methotrexate—testicular cancer	2.28e-05	0.000524	CcSEcCtD
Melphalan—Nausea—Ifosfamide—testicular cancer	2.26e-05	0.000519	CcSEcCtD
Melphalan—Diarrhoea—Cisplatin—testicular cancer	2.24e-05	0.000516	CcSEcCtD
Melphalan—Alopecia—Methotrexate—testicular cancer	2.24e-05	0.000514	CcSEcCtD
Melphalan—Hypersensitivity—Etoposide—testicular cancer	2.21e-05	0.000509	CcSEcCtD
Melphalan—Haemoglobin—Doxorubicin—testicular cancer	2.2e-05	0.000506	CcSEcCtD
Melphalan—Flushing—Epirubicin—testicular cancer	2.2e-05	0.000505	CcSEcCtD
Melphalan—Haemorrhage—Doxorubicin—testicular cancer	2.19e-05	0.000504	CcSEcCtD
Melphalan—Hepatitis—Doxorubicin—testicular cancer	2.19e-05	0.000504	CcSEcCtD
Melphalan—Urinary tract disorder—Doxorubicin—testicular cancer	2.16e-05	0.000498	CcSEcCtD
Melphalan—Asthenia—Etoposide—testicular cancer	2.15e-05	0.000495	CcSEcCtD
Melphalan—Connective tissue disorder—Doxorubicin—testicular cancer	2.15e-05	0.000495	CcSEcCtD
Melphalan—Urethral disorder—Doxorubicin—testicular cancer	2.15e-05	0.000494	CcSEcCtD
Melphalan—Immune system disorder—Epirubicin—testicular cancer	2.14e-05	0.000492	CcSEcCtD
Melphalan—Mediastinal disorder—Epirubicin—testicular cancer	2.13e-05	0.000491	CcSEcCtD
Melphalan—Pruritus—Etoposide—testicular cancer	2.12e-05	0.000488	CcSEcCtD
Melphalan—Arrhythmia—Epirubicin—testicular cancer	2.12e-05	0.000487	CcSEcCtD
Melphalan—Alopecia—Epirubicin—testicular cancer	2.09e-05	0.000481	CcSEcCtD
Melphalan—Vomiting—Cisplatin—testicular cancer	2.08e-05	0.000479	CcSEcCtD
Melphalan—Rash—Cisplatin—testicular cancer	2.07e-05	0.000475	CcSEcCtD
Melphalan—Dermatitis—Cisplatin—testicular cancer	2.06e-05	0.000475	CcSEcCtD
Melphalan—Diarrhoea—Etoposide—testicular cancer	2.05e-05	0.000472	CcSEcCtD
Melphalan—Anaemia—Methotrexate—testicular cancer	2.04e-05	0.000468	CcSEcCtD
Melphalan—Flushing—Doxorubicin—testicular cancer	2.03e-05	0.000468	CcSEcCtD
Melphalan—Immune system disorder—Doxorubicin—testicular cancer	1.98e-05	0.000455	CcSEcCtD
Melphalan—Mediastinal disorder—Doxorubicin—testicular cancer	1.98e-05	0.000454	CcSEcCtD
Melphalan—Leukopenia—Methotrexate—testicular cancer	1.97e-05	0.000453	CcSEcCtD
Melphalan—Arrhythmia—Doxorubicin—testicular cancer	1.96e-05	0.00045	CcSEcCtD
Melphalan—Nausea—Cisplatin—testicular cancer	1.95e-05	0.000448	CcSEcCtD
Melphalan—Alopecia—Doxorubicin—testicular cancer	1.94e-05	0.000445	CcSEcCtD
Melphalan—Cough—Methotrexate—testicular cancer	1.92e-05	0.000442	CcSEcCtD
Melphalan—Convulsion—Methotrexate—testicular cancer	1.91e-05	0.000439	CcSEcCtD
Melphalan—Vomiting—Etoposide—testicular cancer	1.91e-05	0.000439	CcSEcCtD
Melphalan—Anaemia—Epirubicin—testicular cancer	1.91e-05	0.000438	CcSEcCtD
Melphalan—Rash—Etoposide—testicular cancer	1.89e-05	0.000435	CcSEcCtD
Melphalan—Dermatitis—Etoposide—testicular cancer	1.89e-05	0.000435	CcSEcCtD
Melphalan—Myalgia—Methotrexate—testicular cancer	1.88e-05	0.000431	CcSEcCtD
Melphalan—Chest pain—Methotrexate—testicular cancer	1.88e-05	0.000431	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	1.86e-05	0.000428	CcSEcCtD
Melphalan—Leukopenia—Epirubicin—testicular cancer	1.85e-05	0.000424	CcSEcCtD
Melphalan—Cough—Epirubicin—testicular cancer	1.8e-05	0.000414	CcSEcCtD
Melphalan—Anaphylactic shock—Methotrexate—testicular cancer	1.8e-05	0.000413	CcSEcCtD
Melphalan—Convulsion—Epirubicin—testicular cancer	1.79e-05	0.000411	CcSEcCtD
Melphalan—Infection—Methotrexate—testicular cancer	1.79e-05	0.000411	CcSEcCtD
Melphalan—Nausea—Etoposide—testicular cancer	1.78e-05	0.00041	CcSEcCtD
Melphalan—Anaemia—Doxorubicin—testicular cancer	1.76e-05	0.000405	CcSEcCtD
Melphalan—Thrombocytopenia—Methotrexate—testicular cancer	1.76e-05	0.000405	CcSEcCtD
Melphalan—Chest pain—Epirubicin—testicular cancer	1.76e-05	0.000404	CcSEcCtD
Melphalan—Myalgia—Epirubicin—testicular cancer	1.76e-05	0.000404	CcSEcCtD
Melphalan—Skin disorder—Methotrexate—testicular cancer	1.75e-05	0.000402	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	1.74e-05	0.000401	CcSEcCtD
Melphalan—Anorexia—Methotrexate—testicular cancer	1.71e-05	0.000394	CcSEcCtD
Melphalan—Leukopenia—Doxorubicin—testicular cancer	1.71e-05	0.000393	CcSEcCtD
Melphalan—Anaphylactic shock—Epirubicin—testicular cancer	1.68e-05	0.000387	CcSEcCtD
Melphalan—Oedema—Epirubicin—testicular cancer	1.68e-05	0.000387	CcSEcCtD
Melphalan—Hypotension—Methotrexate—testicular cancer	1.68e-05	0.000386	CcSEcCtD
Melphalan—Infection—Epirubicin—testicular cancer	1.67e-05	0.000384	CcSEcCtD
Melphalan—Cough—Doxorubicin—testicular cancer	1.66e-05	0.000383	CcSEcCtD
Melphalan—Convulsion—Doxorubicin—testicular cancer	1.65e-05	0.00038	CcSEcCtD
Melphalan—Thrombocytopenia—Epirubicin—testicular cancer	1.65e-05	0.000379	CcSEcCtD
Melphalan—Tachycardia—Epirubicin—testicular cancer	1.64e-05	0.000378	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Methotrexate—testicular cancer	1.64e-05	0.000377	CcSEcCtD
Melphalan—Skin disorder—Epirubicin—testicular cancer	1.63e-05	0.000376	CcSEcCtD
Melphalan—Chest pain—Doxorubicin—testicular cancer	1.62e-05	0.000373	CcSEcCtD
Melphalan—Myalgia—Doxorubicin—testicular cancer	1.62e-05	0.000373	CcSEcCtD
Melphalan—Paraesthesia—Methotrexate—testicular cancer	1.61e-05	0.000371	CcSEcCtD
Melphalan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	1.61e-05	0.000371	CcSEcCtD
Melphalan—Anorexia—Epirubicin—testicular cancer	1.6e-05	0.000369	CcSEcCtD
Melphalan—Dyspnoea—Methotrexate—testicular cancer	1.6e-05	0.000369	CcSEcCtD
Melphalan—Dyspepsia—Methotrexate—testicular cancer	1.58e-05	0.000364	CcSEcCtD
Melphalan—Hypotension—Epirubicin—testicular cancer	1.57e-05	0.000362	CcSEcCtD
Melphalan—Decreased appetite—Methotrexate—testicular cancer	1.56e-05	0.000359	CcSEcCtD
Melphalan—Anaphylactic shock—Doxorubicin—testicular cancer	1.56e-05	0.000358	CcSEcCtD
Melphalan—Oedema—Doxorubicin—testicular cancer	1.56e-05	0.000358	CcSEcCtD
Melphalan—Gastrointestinal disorder—Methotrexate—testicular cancer	1.55e-05	0.000357	CcSEcCtD
Melphalan—Fatigue—Methotrexate—testicular cancer	1.55e-05	0.000356	CcSEcCtD
Melphalan—Infection—Doxorubicin—testicular cancer	1.55e-05	0.000356	CcSEcCtD
Melphalan—Pain—Methotrexate—testicular cancer	1.54e-05	0.000354	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Epirubicin—testicular cancer	1.53e-05	0.000353	CcSEcCtD
Melphalan—Thrombocytopenia—Doxorubicin—testicular cancer	1.52e-05	0.000351	CcSEcCtD
Melphalan—Tachycardia—Doxorubicin—testicular cancer	1.52e-05	0.000349	CcSEcCtD
Melphalan—Skin disorder—Doxorubicin—testicular cancer	1.51e-05	0.000348	CcSEcCtD
Melphalan—Paraesthesia—Epirubicin—testicular cancer	1.51e-05	0.000347	CcSEcCtD
Melphalan—Dyspnoea—Epirubicin—testicular cancer	1.5e-05	0.000345	CcSEcCtD
Melphalan—Anorexia—Doxorubicin—testicular cancer	1.48e-05	0.000341	CcSEcCtD
Melphalan—Dyspepsia—Epirubicin—testicular cancer	1.48e-05	0.000341	CcSEcCtD
Melphalan—Decreased appetite—Epirubicin—testicular cancer	1.46e-05	0.000336	CcSEcCtD
Melphalan—Hypotension—Doxorubicin—testicular cancer	1.45e-05	0.000335	CcSEcCtD
Melphalan—Gastrointestinal disorder—Epirubicin—testicular cancer	1.45e-05	0.000334	CcSEcCtD
Melphalan—Fatigue—Epirubicin—testicular cancer	1.45e-05	0.000334	CcSEcCtD
Melphalan—Pain—Epirubicin—testicular cancer	1.44e-05	0.000331	CcSEcCtD
Melphalan—Urticaria—Methotrexate—testicular cancer	1.43e-05	0.000328	CcSEcCtD
Melphalan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	1.42e-05	0.000326	CcSEcCtD
Melphalan—Paraesthesia—Doxorubicin—testicular cancer	1.4e-05	0.000321	CcSEcCtD
Melphalan—Dyspnoea—Doxorubicin—testicular cancer	1.39e-05	0.000319	CcSEcCtD
Melphalan—Dyspepsia—Doxorubicin—testicular cancer	1.37e-05	0.000315	CcSEcCtD
Melphalan—Decreased appetite—Doxorubicin—testicular cancer	1.35e-05	0.000311	CcSEcCtD
Melphalan—Gastrointestinal disorder—Doxorubicin—testicular cancer	1.34e-05	0.000309	CcSEcCtD
Melphalan—Fatigue—Doxorubicin—testicular cancer	1.34e-05	0.000309	CcSEcCtD
Melphalan—Urticaria—Epirubicin—testicular cancer	1.34e-05	0.000307	CcSEcCtD
Melphalan—Pain—Doxorubicin—testicular cancer	1.33e-05	0.000306	CcSEcCtD
Melphalan—Hypersensitivity—Methotrexate—testicular cancer	1.32e-05	0.000305	CcSEcCtD
Melphalan—Asthenia—Methotrexate—testicular cancer	1.29e-05	0.000297	CcSEcCtD
Melphalan—Pruritus—Methotrexate—testicular cancer	1.27e-05	0.000293	CcSEcCtD
Melphalan—Hypersensitivity—Epirubicin—testicular cancer	1.24e-05	0.000285	CcSEcCtD
Melphalan—Urticaria—Doxorubicin—testicular cancer	1.24e-05	0.000284	CcSEcCtD
Melphalan—Diarrhoea—Methotrexate—testicular cancer	1.23e-05	0.000283	CcSEcCtD
Melphalan—Asthenia—Epirubicin—testicular cancer	1.21e-05	0.000278	CcSEcCtD
Melphalan—Pruritus—Epirubicin—testicular cancer	1.19e-05	0.000274	CcSEcCtD
Melphalan—Diarrhoea—Epirubicin—testicular cancer	1.15e-05	0.000265	CcSEcCtD
Melphalan—Hypersensitivity—Doxorubicin—testicular cancer	1.15e-05	0.000264	CcSEcCtD
Melphalan—Vomiting—Methotrexate—testicular cancer	1.14e-05	0.000263	CcSEcCtD
Melphalan—Rash—Methotrexate—testicular cancer	1.13e-05	0.000261	CcSEcCtD
Melphalan—Dermatitis—Methotrexate—testicular cancer	1.13e-05	0.00026	CcSEcCtD
Melphalan—Asthenia—Doxorubicin—testicular cancer	1.12e-05	0.000257	CcSEcCtD
Melphalan—Pruritus—Doxorubicin—testicular cancer	1.1e-05	0.000253	CcSEcCtD
Melphalan—Vomiting—Epirubicin—testicular cancer	1.07e-05	0.000246	CcSEcCtD
Melphalan—Nausea—Methotrexate—testicular cancer	1.07e-05	0.000246	CcSEcCtD
Melphalan—Diarrhoea—Doxorubicin—testicular cancer	1.07e-05	0.000245	CcSEcCtD
Melphalan—Rash—Epirubicin—testicular cancer	1.06e-05	0.000244	CcSEcCtD
Melphalan—Dermatitis—Epirubicin—testicular cancer	1.06e-05	0.000244	CcSEcCtD
Melphalan—Nausea—Epirubicin—testicular cancer	1e-05	0.00023	CcSEcCtD
Melphalan—Vomiting—Doxorubicin—testicular cancer	9.9e-06	0.000228	CcSEcCtD
Melphalan—Rash—Doxorubicin—testicular cancer	9.82e-06	0.000226	CcSEcCtD
Melphalan—Dermatitis—Doxorubicin—testicular cancer	9.81e-06	0.000226	CcSEcCtD
Melphalan—Nausea—Doxorubicin—testicular cancer	9.25e-06	0.000213	CcSEcCtD
